Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 527 across all filing types
Latest filing 2025-01-07 Regulatory Filings
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate related to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, concerning dematerialisation of shares for the quarter ended December 31, 2024. It is a confirmation letter from the Registrar and Share Transfer Agent to the company secretary, confirming actions taken on share certificates during the quarter. The document is short (3241 characters) and serves as a regulatory compliance confirmation rather than a financial report or announcement of voting results, management changes, or capital changes. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and regulatory confirmations that do not fit other specific categories.
2025-01-07 English
Updates
Regulatory Filings Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding a change in the name of the company's Registrar and Share Transfer Agent (RTA). It references compliance with SEBI Listing Regulations and provides updated information about the RTA's name change. The document is short (1586 characters) and serves as an announcement of a corporate administrative update rather than a financial report or detailed filing. It does not contain financial data, audit information, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-31 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification from a company to stock exchanges regarding the closure of the trading window in compliance with insider trading regulations. It mentions the upcoming announcement of unaudited financial results for the quarter and nine months ending December 31, 2024, but does not contain any financial data or the results themselves. The document is short (1817 characters) and serves as an announcement related to regulatory compliance and trading restrictions rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-27 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying the incorporation of a wholly owned subsidiary company. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to disclosure of material events. The document is an announcement of a corporate event (subsidiary incorporation) rather than a financial report or detailed filing. It is short (2118 characters) and serves as a regulatory announcement. This fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous compliance and disclosure announcements that do not fit other specific categories.
2024-12-24 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding an update on the acquisition of Unistar Thai Co. Limited by Rossari Global DMCC, a subsidiary of Rossari Biotech Limited. It references prior disclosure under Regulation 30 of the SEBI Listing Regulations, which pertains to continuous disclosure obligations for listed companies. The document provides an update on the completion of the acquisition transaction, which is a capital or financing event. The document is short (1881 characters) and is an announcement of an event rather than a detailed report or financial statement. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2024-12-11 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the outcome of a Board Meeting held on November 30, 2024. It announces the approval of the incorporation of a wholly owned subsidiary in the Kingdom of Saudi Arabia. The document references compliance with SEBI Listing Regulations, specifically Regulation 30, which pertains to disclosure of material events. The content is an announcement of a corporate action (incorporation of a subsidiary) rather than a detailed report or financial statement. It does not contain financial data, audit information, or detailed management discussion. The document is a regulatory announcement informing stakeholders about a board decision and related compliance disclosures. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2024-11-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.